Global and China Colorectal Cancer Drugs Market Insights, Forecast to 2027

Global and China Colorectal Cancer Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Colorectal Cancer Drugs Product Introduction
1.2 Market
1.2.1 Global Colorectal Cancer Drugs Market Size Growth Rate
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Market
1.3.1 Global Colorectal Cancer Drugs Market Size Growth Rate
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Colorectal Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Colorectal Cancer Drugs Revenue 2016-2027
2.1.2 Global Colorectal Cancer Drugs Sales 2016-2027
2.2 Global Colorectal Cancer Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Colorectal Cancer Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Colorectal Cancer Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Colorectal Cancer Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Colorectal Cancer Drugs Revenue Forecast by Region (2022-2027)
3 Global Colorectal Cancer Drugs Competitor Landscape by Players
3.1 Global Top Colorectal Cancer Drugs Manufacturers by Sales
3.1.1 Global Colorectal Cancer Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Colorectal Cancer Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Colorectal Cancer Drugs Manufacturers by Revenue
3.2.1 Key Colorectal Cancer Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Colorectal Cancer Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Colorectal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Colorectal Cancer Drugs Revenue in 2020
3.2.6 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Colorectal Cancer Drugs Price by Manufacturers
3.4 Global Colorectal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Colorectal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data (2016-2027)
4.1 Global Colorectal Cancer Drugs Market Size (2016-2021)
4.1.1 Global Colorectal Cancer Drugs Sales (2016-2021)
4.1.2 Global Colorectal Cancer Drugs Revenue (2016-2021)
4.1.3 Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021)
4.2 Global Colorectal Cancer Drugs Market Size Forecast (2022-2027)
4.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
4.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
4.2.3 Colorectal Cancer Drugs Average Selling Price (ASP) Forecast (2022-2027)
5 Breakdown Data (2016-2027)
5.1 Global Colorectal Cancer Drugs Market Size (2016-2021)
5.1.1 Global Colorectal Cancer Drugs Sales (2016-2021)
5.1.2 Global Colorectal Cancer Drugs Revenue (2016-2021)
5.1.3 Colorectal Cancer Drugs Price (2016-2021)
5.2 Colorectal Cancer Drugs Market Size Forecast (2022-2027)
5.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
5.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
5.2.3 Global Colorectal Cancer Drugs Price Forecast (2022-2027)
6 China by Players, and
6.1 China Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
6.1.1 China Colorectal Cancer Drugs Sales YoY Growth 2016-2027
6.1.2 China Colorectal Cancer Drugs Revenue YoY Growth 2016-2027
6.1.3 China Colorectal Cancer Drugs Market Share in Global Market 2016-2027
6.2 China Colorectal Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Colorectal Cancer Drugs Players by Sales (2016-2021)
6.2.2 China Top Colorectal Cancer Drugs Players by Revenue (2016-2021)
6.3 China Colorectal Cancer Drugs Historic Market Review (2016-2021)
6.3.1 China Colorectal Cancer Drugs Sales Market Share (2016-2021)
6.3.2 China Colorectal Cancer Drugs Revenue Market Share (2016-2021)
6.3.3 China Colorectal Cancer Drugs Price (2016-2021)
6.4 China Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
6.4.1 China Colorectal Cancer Drugs Sales Forecast (2022-2027)
6.4.2 China Colorectal Cancer Drugs Revenue Forecast (2022-2027)
6.4.3 China Colorectal Cancer Drugs Price Forecast (2022-2027)
6.5 China Colorectal Cancer Drugs Historic Market Review (2016-2021)
6.5.1 China Colorectal Cancer Drugs Sales Market Share (2016-2021)
6.5.2 China Colorectal Cancer Drugs Revenue Market Share (2016-2021)
6.5.3 China Colorectal Cancer Drugs Price (2016-2021)
6.6 China Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
6.6.1 China Colorectal Cancer Drugs Sales Forecast (2022-2027)
6.6.2 China Colorectal Cancer Drugs Revenue Forecast (2022-2027)
6.6.3 China Colorectal Cancer Drugs Price Forecast (2022-2027)
7 North America
7.1 North America Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
7.2 North America Colorectal Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Colorectal Cancer Drugs Sales by Country (2016-2021)
7.2.2 North America Colorectal Cancer Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico
8 Asia Pacific
8.1 Asia Pacific Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Colorectal Cancer Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Colorectal Cancer Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
9.2 Europe Colorectal Cancer Drugs Market Facts & Figures by Country
9.2.1 Europe Colorectal Cancer Drugs Sales by Country (2016-2021)
9.2.2 Europe Colorectal Cancer Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Colorectal Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Colorectal Cancer Drugs Sales by Country (2016-2021)
10.2.2 Latin America Colorectal Cancer Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Colorectal Cancer Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AB Science
12.1.1 AB Science Corporation Information
12.1.2 AB Science Description and Business Overview
12.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AB Science Colorectal Cancer Drugs Products Offered
12.1.5 AB Science Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Description and Business Overview
12.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Colorectal Cancer Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Array BioPharma
12.3.1 Array BioPharma Corporation Information
12.3.2 Array BioPharma Description and Business Overview
12.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
12.3.5 Array BioPharma Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Colorectal Cancer Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Corporation Information
12.5.2 Boehringer Ingelheim Description and Business Overview
12.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
12.5.5 Boehringer Ingelheim Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Elli Lilly
12.7.1 Elli Lilly Corporation Information
12.7.2 Elli Lilly Description and Business Overview
12.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
12.7.5 Elli Lilly Recent Development
12.8 Roch
12.8.1 Roch Corporation Information
12.8.2 Roch Description and Business Overview
12.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roch Colorectal Cancer Drugs Products Offered
12.8.5 Roch Recent Development
12.9 Hutchison MediPharma
12.9.1 Hutchison MediPharma Corporation Information
12.9.2 Hutchison MediPharma Description and Business Overview
12.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
12.9.5 Hutchison MediPharma Recent Development
12.10 Merck & Co., Inc.
12.10.1 Merck & Co., Inc. Corporation Information
12.10.2 Merck & Co., Inc. Description and Business Overview
12.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
12.10.5 Merck & Co., Inc. Recent Development
12.11 AB Science
12.11.1 AB Science Corporation Information
12.11.2 AB Science Description and Business Overview
12.11.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AB Science Colorectal Cancer Drugs Products Offered
12.11.5 AB Science Recent Development
12.12 Regeneron
12.12.1 Regeneron Corporation Information
12.12.2 Regeneron Description and Business Overview
12.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Regeneron Products Offered
12.12.5 Regeneron Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Description and Business Overview
12.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Products Offered
12.13.5 Sanofi Recent Development
12.14 Sumitomo Dainippon
12.14.1 Sumitomo Dainippon Corporation Information
12.14.2 Sumitomo Dainippon Description and Business Overview
12.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sumitomo Dainippon Products Offered
12.14.5 Sumitomo Dainippon Recent Development
12.15 Taiho Pharmaceutical
12.15.1 Taiho Pharmaceutical Corporation Information
12.15.2 Taiho Pharmaceutical Description and Business Overview
12.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Taiho Pharmaceutical Products Offered
12.15.5 Taiho Pharmaceutical Recent Development
12.16 Vaccinogen
12.16.1 Vaccinogen Corporation Information
12.16.2 Vaccinogen Description and Business Overview
12.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Vaccinogen Products Offered
12.16.5 Vaccinogen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Colorectal Cancer Drugs Industry Trends
13.2 Colorectal Cancer Drugs Market Drivers
13.3 Colorectal Cancer Drugs Market Challenges
13.4 Colorectal Cancer Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Colorectal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Colorectal Cancer Drugs Market Size Growth Rate , 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 3. Major Manufacturers of Epidermal Growth Factor Receptor (EGFR) Inhibitors
Table 4. Major Manufacturers of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Table 5. Major Manufacturers of BRAF or MEK Inhibitors
Table 6. Major Manufacturers of Tyrosine Kinase (TKI) Inhibitors
Table 7. Major Manufacturers of Immunomodulators
Table 8. Global Colorectal Cancer Drugs Market Size Growth Rate (2021-2027) & (MT)
Table 9. Global Colorectal Cancer Drugs Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Colorectal Cancer Drugs Sales by Regions (2016-2021) & (MT)
Table 11. Global Colorectal Cancer Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global Colorectal Cancer Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Colorectal Cancer Drugs Sales Forecast by Region (2022-2027) & (MT)
Table 14. Global Colorectal Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Colorectal Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Colorectal Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Colorectal Cancer Drugs Sales by Manufacturers (2016-2021) (MT)
Table 18. Global Colorectal Cancer Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Colorectal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. Colorectal Cancer Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Colorectal Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2020)
Table 24. Key Manufacturers Colorectal Cancer Drugs Price (2016-2021) (USD/Kg)
Table 25. Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Colorectal Cancer Drugs Product Type
Table 27. Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 30. Global Colorectal Cancer Drugs Sales Share (2016-2021)
Table 31. Global Colorectal Cancer Drugs Revenue (2016-2021) (US$ Million)
Table 32. Global Colorectal Cancer Drugs Revenue Share (2016-2021)
Table 33. Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021) & (USD/Kg)
Table 34. Global Colorectal Cancer Drugs Sales Forecast (2022-2027) & (MT)
Table 35. Global Colorectal Cancer Drugs Sales Market Share Forecast (2022-2027)
Table 36. Global Colorectal Cancer Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Colorectal Cancer Drugs Revenue Market Share Forecast (2022-2027)
Table 38. Global Colorectal Cancer Drugs Average Selling Price (ASP) Forecast (2022-2027) & (USD/Kg)
Table 39. Global Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 40. Global Colorectal Cancer Drugs Sales Share (2016-2021)
Table 41. Global Colorectal Cancer Drugs Revenue (2016-2021) (US$ Million)
Table 42. Global Colorectal Cancer Drugs Revenue Share (2016-2021)
Table 43. Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021) & (USD/Kg)
Table 44. Global Colorectal Cancer Drugs Sales Forecast (2022-2027) & (MT)
Table 45. Global Colorectal Cancer Drugs Sales Market Share Forecast (2022-2027)
Table 46. Global Colorectal Cancer Drugs Revenue Forecast (2022-2027) & (US$ Million)
Table 47. Global Colorectal Cancer Drugs Revenue Market Share Forecast (2022-2027)
Table 48. Global Colorectal Cancer Drugs Average Selling Price (ASP) Forecast (2022-2027) & (USD/Kg)
Table 49. China Colorectal Cancer Drugs Sales (MT) of Key Companies (2016-2021)
Table 50. China Colorectal Cancer Drugs Sales Share by Company (2016-2021)
Table 51. China Colorectal Cancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. China Colorectal Cancer Drugs Revenue Share by Company (2016-2021)
Table 53. China Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 54. China Colorectal Cancer Drugs Sales Share (2016-2021)
Table 55. China Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2016-2021)
Table 56. China Colorectal Cancer Drugs Price (USD/Kg) (2016-2021)
Table 57. China Colorectal Cancer Drugs Sales (MT) (2022-2027)
Table 58. China Colorectal Cancer Drugs Sales Share (2022-2027)
Table 59. China Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2022-2027)
Table 60. China Colorectal Cancer Drugs Revenue Share (2022-2027)
Table 61. China Colorectal Cancer Drugs Price (USD/Kg) (2022-2027)
Table 62. China Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 63. China Colorectal Cancer Drugs Sales Share (2016-2021)
Table 64. China Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2016-2021)
Table 65. China Colorectal Cancer Drugs Price (USD/Kg) (2016-2021)
Table 66. China Colorectal Cancer Drugs Sales (MT) (2022-2027)
Table 67. China Colorectal Cancer Drugs Sales Share (2022-2027)
Table 68. China Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2022-2027)
Table 69. China Colorectal Cancer Drugs Revenue Share (2022-2027)
Table 70. China Colorectal Cancer Drugs Price (USD/Kg) (2022-2027)
Table 71. North America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 72. North America Colorectal Cancer Drugs Sales Market Share by Country (2016-2021)
Table 73. North America Colorectal Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Colorectal Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Colorectal Cancer Drugs Sales by Region (2016-2021) & (MT)
Table 76. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 80. Europe Colorectal Cancer Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe Colorectal Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 84. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Colorectal Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 88. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 91. AB Science Corporation Information
Table 92. AB Science Description and Business Overview
Table 93. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 94. AB Science Colorectal Cancer Drugs Product
Table 95. AB Science Recent Development
Table 96. Amgen Corporation Information
Table 97. Amgen Description and Business Overview
Table 98. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 99. Amgen Product
Table 100. Amgen Recent Development
Table 101. Array BioPharma Corporation Information
Table 102. Array BioPharma Description and Business Overview
Table 103. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 104. Array BioPharma Product
Table 105. Array BioPharma Recent Development
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Business Overview
Table 108. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 109. Bayer Product
Table 110. Bayer Recent Development
Table 111. Boehringer Ingelheim Corporation Information
Table 112. Boehringer Ingelheim Description and Business Overview
Table 113. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 114. Boehringer Ingelheim Product
Table 115. Boehringer Ingelheim Recent Development
Table 116. Bristol-Myers Squibb Corporation Information
Table 117. Bristol-Myers Squibb Description and Business Overview
Table 118. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 119. Bristol-Myers Squibb Product
Table 120. Bristol-Myers Squibb Recent Development
Table 121. Elli Lilly Corporation Information
Table 122. Elli Lilly Description and Business Overview
Table 123. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 124. Elli Lilly Product
Table 125. Elli Lilly Recent Development
Table 126. Roch Corporation Information
Table 127. Roch Description and Business Overview
Table 128. Roch Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 129. Roch Product
Table 130. Roch Recent Development
Table 131. Hutchison MediPharma Corporation Information
Table 132. Hutchison MediPharma Description and Business Overview
Table 133. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 134. Hutchison MediPharma Product
Table 135. Hutchison MediPharma Recent Development
Table 136. Merck & Co., Inc. Corporation Information
Table 137. Merck & Co., Inc. Description and Business Overview
Table 138. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 139. Merck & Co., Inc. Product
Table 140. Merck & Co., Inc. Recent Development
Table 141. Mologen Corporation Information
Table 142. Mologen Description and Business Overview
Table 143. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 144. Mologen Product
Table 145. Mologen Recent Development
Table 146. Regeneron Corporation Information
Table 147. Regeneron Description and Business Overview
Table 148. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 149. Regeneron Product
Table 150. Regeneron Recent Development
Table 151. Sanofi Corporation Information
Table 152. Sanofi Description and Business Overview
Table 153. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 154. Sanofi Product
Table 155. Sanofi Recent Development
Table 156. Sumitomo Dainippon Corporation Information
Table 157. Sumitomo Dainippon Description and Business Overview
Table 158. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 159. Sumitomo Dainippon Product
Table 160. Sumitomo Dainippon Recent Development
Table 161. Taiho Pharmaceutical Corporation Information
Table 162. Taiho Pharmaceutical Description and Business Overview
Table 163. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 164. Taiho Pharmaceutical Product
Table 165. Taiho Pharmaceutical Recent Development
Table 166. Vaccinogen Corporation Information
Table 167. Vaccinogen Description and Business Overview
Table 168. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 169. Vaccinogen Product
Table 170. Vaccinogen Recent Development
Table 171. Colorectal Cancer Drugs Market Trends
Table 172. Colorectal Cancer Drugs Market Drivers
Table 173. Colorectal Cancer Drugs Market Challenges
Table 174. Colorectal Cancer Drugs Market Restraints
Table 175. Colorectal Cancer Drugs Customers List
Table 176. Colorectal Cancer Drugs Distributors List
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share in 2020 & 2027
Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
Figure 6. BRAF or MEK Inhibitors Product Picture
Figure 7. Tyrosine Kinase (TKI) Inhibitors Product Picture
Figure 8. Immunomodulators Product Picture
Figure 9. Global Colorectal Cancer Drugs Sales Market Share in 2020 & 2027
Figure 10. Radiotherapy
Figure 11. Chemotherapy
Figure 12. Colorectal Cancer Drugs Report Years Considered
Figure 13. Global Colorectal Cancer Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Colorectal Cancer Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Colorectal Cancer Drugs Sales 2016-2027 (MT)
Figure 16. Global Colorectal Cancer Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Colorectal Cancer Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Colorectal Cancer Drugs Sales Market Share by Region in 2020
Figure 19. Global Colorectal Cancer Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Colorectal Cancer Drugs Revenue Market Share by Region in 2020
Figure 21. Global Colorectal Cancer Drugs Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Colorectal Cancer Drugs Revenue in 2020
Figure 23. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
Figure 25. Global Colorectal Cancer Drugs Sales Market Share in 2020
Figure 26. Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
Figure 27. Global Colorectal Cancer Drugs Revenue Market Share in 2020
Figure 28. Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
Figure 29. Global Colorectal Cancer Drugs Sales Market Share in 2020
Figure 30. Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
Figure 31. Global Colorectal Cancer Drugs Revenue Market Share in 2020
Figure 32. China Colorectal Cancer Drugs Sales Growth Rate 2016-2027 (MT)
Figure 33. China Colorectal Cancer Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Colorectal Cancer Drugs Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Colorectal Cancer Drugs Players Market Share by Revenue in Colorectal Cancer Drugs in 2020
Figure 36. China Colorectal Cancer Drugs Revenue Share (2016-2021)
Figure 37. China Colorectal Cancer Drugs Revenue Growth Rate in 2016 & 2020
Figure 38. China Colorectal Cancer Drugs Revenue Share (2016-2021)
Figure 39. China Colorectal Cancer Drugs Revenue Growth Rate in 2016 & 2020
Figure 40. North America Colorectal Cancer Drugs Sales Growth Rate 2016-2021 (MT)
Figure 41. North America Colorectal Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Colorectal Cancer Drugs Sales Market Share by Country in 2020
Figure 43. North America Colorectal Cancer Drugs Revenue Market Share by Country in 2020
Figure 44. United States Colorectal Cancer Drugs Sales Growth Rate (2016-2021) (MT)
Figure 45. United States Colorectal Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Colorectal Cancer Drugs Sales Growth Rate (2016-2021) (MT)
Figure 47. Canada Colorectal Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Mexico Colorectal Cancer Drugs Sales Growth Rate (2016-2021) (MT)
Figure 49. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Colorectal Cancer Drugs Sales Growth Rate 2016-2021 (MT)
Figure 51. Europe Colorectal Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Colorectal Cancer Drugs Sales Market Share by Country in 2020
Figure 53. Europe Colorectal Cancer Drugs Revenue Market Share by Country in 2020
Figure 54. Germany Colorectal Cancer Drugs Sales Growth Rate (2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs